WINTER SPRINGS, Fla., May 29, 2025 - Iradimed Corporation $(IRMD)$, a leading provider of innovative medical devices for MRI environments, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MRidium® 3870 IV Infusion Pump System. This next-generation, MRI-compatible infusion pump reinforces Iradimed's unique position as the sole supplier of non-magnetic MRI infusion pump devices, a leadership role they have held since the introduction of their first-generation device in 2005. The MRidium® 3870 is designed to enhance patient safety and operational efficiency during MRI procedures, featuring a non-magnetic ultrasonic pump motor and advanced safety features. The company plans a strategic rollout starting in the fourth quarter of 2025, with full commercial distribution expected to increase throughout 2026.